Dr. Paul Lammers has served as a member of Mirna’s board of directors and as President and Chief Executive Officer since November 2009. Previously, Dr. Lammers was the President of Repros Therapeutics Inc., a biopharmaceutical company. Dr. Lammers has also served as the Chief Medical Officer for EMD Serono, Inc., a biopharmaceutical division of Merck KGaA, Senior Vice President of clinical and regulatory affairs at Zonagen, Inc., which later became Repros Therapeutics, and Organon International, a pharmaceutical company, spending eight years in the commercial and clinical operations in Europe and the United States. Dr. Lammers received an M.Sc. and M.D. from the Catholic University (Radboud University) in Nijmegen, The Netherlands.

Ms. Casi DeYoung joined Mirna Therapeutics in March 2014 as Chief Business Officer. Prior to Mirna, Ms. DeYoung served as Vice President of Business Development at Reata Pharmaceuticals. Previously, Ms. DeYoung served as the Vice President of Business Development for ODC Therapy, Inc., an immunotherapy company. Ms. DeYoung has also served in various commercial and business development roles, including Director of Global Oncology Operations for EMD Pharmaceuticals, Inc., the U.S. affiliate of Merck KGaA. Ms. DeYoung received a bachelor’s degree in chemistry from Southwestern University and an M.B.A. from the University of Texas at Austin.

Alan Fuhrman has served as our Chief Financial Officer since September 2015. Mr. Fuhrman previously served as the Chief Financial Officer of Ambit Biosciences Corporation, a biopharmaceutical company, including through the company’s initial public offering in 2013 and until its sale to Daiichi Sankyo for up to $410 million. Prior to this role, Mr. Fuhrman served as Chief Financial Officer of Naviscan, Inc., a privately held medical imaging company and as Chief Financial Officer of Sonus Pharmaceuticals, Inc., a pharmaceutical company. Mr. Fuhrman is a member of the board of directors of Loxo Oncology, Inc. Earlier in Mr. Fuhrman’s career he practiced as a CPA with Coopers and Lybrand. Mr. Fuhrman received a B.S. in both Business Administration and Agricultural Economics from Montana State University.